PRCD inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of PRCD, a protein known as Progressive Rod-Cone Degeneration protein. PRCD plays a crucial role in the maintenance and function of photoreceptor cells in the retina, particularly in the outer segments of rods and cones, which are responsible for light detection and vision. Although PRCD's precise molecular functions are not fully understood, it is believed to be involved in the structural integrity and stability of the photoreceptor outer segments, ensuring proper phototransduction-the process by which light is converted into electrical signals for visual processing. By inhibiting PRCD, researchers can investigate its role in maintaining the health of photoreceptor cells and its involvement in visual function.
In research settings, PRCD inhibitors are valuable tools for exploring the molecular mechanisms underlying photoreceptor function and the structural components of the retina. By blocking PRCD activity, scientists can study how the inhibition affects the organization and stability of the photoreceptor outer segments, focusing on the consequences for light detection and signal transmission in the retina. This inhibition provides insights into how PRCD interacts with other proteins and cellular components critical for maintaining the photoreceptor architecture and its proper functioning. Additionally, PRCD inhibitors offer a deeper understanding of the pathways that regulate photoreceptor health and visual processing, contributing to a broader exploration of retinal biology and the molecular networks that support vision. Through these studies, the use of PRCD inhibitors enhances our knowledge of the structural dynamics of photoreceptor cells and the molecular processes essential for visual perception.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is involved in the visual cycle and gene expression regulation in retinal cells, which may impact PRCD expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor that can change chromatin structure and potentially alter PRCD gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor may affect chromatin remodeling and gene expression in retinal cells, possibly influencing PRCD. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, as a histone deacetylase inhibitor, could modify gene expression patterns in retinal cells, potentially including PRCD. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could change the methylation status of the PRCD gene, affecting its expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is another DNA methyltransferase inhibitor that could influence gene expression, potentially including PRCD. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
As an inhibitor of sirtuins, nicotinamide might impact epigenetic regulation and influence PRCD expression. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is essential for eye health, and its dysregulation could affect retinal metabolism and gene expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, potentially affecting DNA synthesis and gene expression, including that of PRCD. | ||||||